CVS unveils AI platform raises 2025 forecast, projecting $400B revenue and improved earnings to enhance consumer healthcare experience.

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health shares climbed Tuesday after the health conglomerate raised its full-year outlook and outlined plans for a new AI ...

CVS is bringing together its disparate businesses onto one platform, and giving its rivals the option to add their products ...

CVS Caremark settles pharmacy underpayment allegations for $5M, reimbursing Oklahoma pharmacies for 68,099 prescriptions filled from 2024 to 2025.

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...

It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health shared that it is launching an open consumer engagement platform to simplify care and improve health.

CVS Health (CVS) stock in focus as the company raises 2025 financial guidance, but projects 2026 revenue below consensus.

CVS Health used its Investor Day on Tuesday as a megaphone for the retailer’s success, raising its full-year financial ...